This webinar took place on May 20, 2021.Fill in this form to access the recording

2021

Thought Leadership Webinar Series

With guest speaker Prof. Bernd Wollscheid from
ETH Zurich

With guest speaker Prof. Bernd Wollscheid from ETH Zurich

The Tumor Profiler Study: Integrated, multi-omic, functional tumor profiling for clinical decision support

PreOmics is happy to continue the Thought Leadership Webinar Series 2021 with our visionary guest speaker Prof. Bernd Wollscheid from the Swiss Federal Institute of Technology, Department of Health Sciences and Technology, Institute of Translational Medicine & Swiss Institute of Bioinformatics. Bernd's talk is titled "The Tumor Profiler Study: Integrated, multi-omic, functional tumor profiling for clinical decision support". 


Abstract:

Recent technological advances allow profiling of tumor samples to an unparalleled level with respect to molecular and spatial composition as well as treatment response. In this webinar, Bernd will briefly present/discuss the Tumor Profiler (TuPro) project. TuPro aims to show that more comprehensive molecular information can lead to advanced mechanistic insights of a patient’s tumor, enables prognostic and predictive biomarker discovery, and has the potential to support clinical decision making. Coordinated and automated processing of clinical biospecimens plays a key role in enabling such projects and is critical for data quality/analysis.


This is part 2 of our series of webinars from leading-edge researchers giving their proteomic and protein analysis visions for the future.

Agenda and Speakers

May 20, 2021 (09:00 EST | 14:00 BST | 15:00 CET)


  • 5 min - Welcome and intro by Garwin Pichler, PreOmics
  • 30 min - Presentation by Prof. Bernd Wollscheid: "The Tumor Profiler Study: Integrated, multi-omic, functional tumor profiling for clinical decision support"
  • 15 min - Q&A session

Your questions answered by experts:

Bernd Wollscheid - Professor at Swiss Federal Institute of Technology, Department of Health Sciences and Technology, Institute of Translational Medicine & Swiss Institute of Bioinformatics


Bernd Wollscheid is Professor of Molecular Health in the Department of Health Sciences and Technology at the Swiss Federal Institute of Technology in Zürich / ETH Zürich, Switzerland.

More info at http://wlab.ethz.ch/wollscheidlab

Garwin Pichler - Founder and CEO at PreOmics


Garwin is co-founder and CEO here at PreOmics. Garwin holds a PhD in Biochemistry from the LMU Munich (Germany). Garwin joined Nils Kulak working on the iST Technology in the Matthias Mann lab. Together they founded PreOmics in 2016 and Garwin is responsible for Finances, Business Development, Investor Relationship and HR.

Copyright ©2020 All Rights Reserved

PreOmics GmbH
Am Klopferspitz 19

D-82152 Planegg/Martinsried

Phone: +49-89-2314163-0

Fax: +49-89-2314163-99

E-mail: info@preomics.com